Page last updated: 2024-11-08

t 1105

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

T 1105: has antiviral activity; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID294642
CHEMBL ID4167765
SCHEMBL ID1338425
MeSH IDM0537273

Synonyms (38)

Synonym
3-hydroxy-pyrazine-2-carboxamide
pyrazine-2-carboxamide, 3-hydroxy-
pyrazinecarboxamide, 3,4-dihydro-3-oxo-
2-oxo-1h-pyrazine-3-carboxamide
3-oxo-3,4-dihydropyrazine-2-carboxamide
t-1105
55321-99-8
nsc163503
nsc-163503
AKOS005166970
3-hydroxypyrazine-2-carboxamide
SCHEMBL1338425
unii-5r3a375f7a
nsc 163503
2-pyrazinecarboxamide, 3,4-dihydro-3-oxo-
t 1105
5r3a375f7a ,
AKOS015950901
FT-0686914
AM20070364
mfcd00233977
SY017450
H1485
3-hydroxy-2-pyrazinecarboxamide
2-pyrazinecarboxamide, 3-hydroxy-
3-hydroxy-2-pyrazinecarboxamide #
Q-103306
3-hydroxypyrazine-2-carboxamine
AC-25579
DTXSID10203888
CS-W016480
A846786
HY-W015764
3,4-dihydro-3-oxo-2-pyrazinecarboxamide
BCP03021
CHEMBL4167765
EN300-114097
Z1201619905
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (27)

Assay IDTitleYearJournalArticle
AID1505503Prodrug activation in MDCK cells assessed as T-1105-RMP formation at 714 uM after 19 hrs by RP-HPLC-UV analysis2018Journal of medicinal chemistry, Jul-26, Volume: 61, Issue:14
Prodrugs of the Phosphoribosylated Forms of Hydroxypyrazinecarboxamide Pseudobase T-705 and Its De-Fluoro Analogue T-1105 as Potent Influenza Virus Inhibitors.
AID1505493Cytotoxicity against MDCK cells assessed as reduction in cell viability after 3 days by formazan-based MTS assay2018Journal of medicinal chemistry, Jul-26, Volume: 61, Issue:14
Prodrugs of the Phosphoribosylated Forms of Hydroxypyrazinecarboxamide Pseudobase T-705 and Its De-Fluoro Analogue T-1105 as Potent Influenza Virus Inhibitors.
AID1505495Antiviral activity against Influenza virus A/X-31 infected in HGPRT deficient 6-thioguanine-resistant MDCK cells assessed as reduction in viral replication at 3 days post infection by formazan-based MTS assay2018Journal of medicinal chemistry, Jul-26, Volume: 61, Issue:14
Prodrugs of the Phosphoribosylated Forms of Hydroxypyrazinecarboxamide Pseudobase T-705 and Its De-Fluoro Analogue T-1105 as Potent Influenza Virus Inhibitors.
AID1505548Antiviral activity against Influenza virus A/X-31 infected in MDCK cells assessed as inhibition of one cycle viral RNA sytheis at 25 uM added at > 2 to 8 hrs post infection and measured at 10 hrs post infection by RT-qPCR method2018Journal of medicinal chemistry, Jul-26, Volume: 61, Issue:14
Prodrugs of the Phosphoribosylated Forms of Hydroxypyrazinecarboxamide Pseudobase T-705 and Its De-Fluoro Analogue T-1105 as Potent Influenza Virus Inhibitors.
AID1505490Antiviral activity against Influenza virus B/Ned/537/05 infected in MDCK cells assessed as reduction in viral replication at 3 days post infection by microscopic analysis2018Journal of medicinal chemistry, Jul-26, Volume: 61, Issue:14
Prodrugs of the Phosphoribosylated Forms of Hydroxypyrazinecarboxamide Pseudobase T-705 and Its De-Fluoro Analogue T-1105 as Potent Influenza Virus Inhibitors.
AID1505489Antiviral activity against Influenza virus A/X-31 infected in MDCK cells assessed as reduction in viral replication at 3 days post infection by formazan-based MTS assay2018Journal of medicinal chemistry, Jul-26, Volume: 61, Issue:14
Prodrugs of the Phosphoribosylated Forms of Hydroxypyrazinecarboxamide Pseudobase T-705 and Its De-Fluoro Analogue T-1105 as Potent Influenza Virus Inhibitors.
AID1505501Prodrug activation in MDCK cells assessed as parent compound remaining at 714 uM after 19 hrs by RP-HPLC-UV analysis2018Journal of medicinal chemistry, Jul-26, Volume: 61, Issue:14
Prodrugs of the Phosphoribosylated Forms of Hydroxypyrazinecarboxamide Pseudobase T-705 and Its De-Fluoro Analogue T-1105 as Potent Influenza Virus Inhibitors.
AID1505547Antiviral activity against Influenza virus A/X-31 infected in MDCK cells assessed as inhibition of one cycle viral RNA sytheis at 25 uM added at 2 hrs post infection and measured at 10 hrs post infection by RT-qPCR method2018Journal of medicinal chemistry, Jul-26, Volume: 61, Issue:14
Prodrugs of the Phosphoribosylated Forms of Hydroxypyrazinecarboxamide Pseudobase T-705 and Its De-Fluoro Analogue T-1105 as Potent Influenza Virus Inhibitors.
AID1505491Antiviral activity against Influenza virus B/Ned/537/05 infected in MDCK cells assessed as reduction in viral replication at 3 days post infection by formazan-based MTS assay2018Journal of medicinal chemistry, Jul-26, Volume: 61, Issue:14
Prodrugs of the Phosphoribosylated Forms of Hydroxypyrazinecarboxamide Pseudobase T-705 and Its De-Fluoro Analogue T-1105 as Potent Influenza Virus Inhibitors.
AID1505488Antiviral activity against Influenza virus A/X-31 infected in MDCK cells assessed as reduction in viral replication at 3 days post infection by microscopic analysis2018Journal of medicinal chemistry, Jul-26, Volume: 61, Issue:14
Prodrugs of the Phosphoribosylated Forms of Hydroxypyrazinecarboxamide Pseudobase T-705 and Its De-Fluoro Analogue T-1105 as Potent Influenza Virus Inhibitors.
AID1505505Prodrug activation in HGPRT deficient 6-thioguanine-resistant MDCK cells assessed as T-1105-RMP formation at 714 uM by RP-HPLC-UV analysis2018Journal of medicinal chemistry, Jul-26, Volume: 61, Issue:14
Prodrugs of the Phosphoribosylated Forms of Hydroxypyrazinecarboxamide Pseudobase T-705 and Its De-Fluoro Analogue T-1105 as Potent Influenza Virus Inhibitors.
AID1505496Antiviral activity against Influenza virus B/Ned/537/05 infected in HGPRT deficient 6-thioguanine-resistant MDCK cells assessed as reduction in viral replication at 3 days post infection by microscopic analysis2018Journal of medicinal chemistry, Jul-26, Volume: 61, Issue:14
Prodrugs of the Phosphoribosylated Forms of Hydroxypyrazinecarboxamide Pseudobase T-705 and Its De-Fluoro Analogue T-1105 as Potent Influenza Virus Inhibitors.
AID1505530Antiviral activity against Influenza virus A/X-31 infected in MDCK cells assessed as inhibition of one cycle viral RNA synthesis at 12 to 50 uM preincubated with cells for 12 hrs followed by viral infection measured after 10 hrs post infection by RT-qPCR 2018Journal of medicinal chemistry, Jul-26, Volume: 61, Issue:14
Prodrugs of the Phosphoribosylated Forms of Hydroxypyrazinecarboxamide Pseudobase T-705 and Its De-Fluoro Analogue T-1105 as Potent Influenza Virus Inhibitors.
AID1505527Antiviral activity against Influenza virus A/X-31 infected in MDCK cells assessed as inhibition of one cycle viral RNA synthesis at 25 uM preincubated with cells for 12 hrs followed by viral infection measured after 10 hrs post infection by RT-qPCR method2018Journal of medicinal chemistry, Jul-26, Volume: 61, Issue:14
Prodrugs of the Phosphoribosylated Forms of Hydroxypyrazinecarboxamide Pseudobase T-705 and Its De-Fluoro Analogue T-1105 as Potent Influenza Virus Inhibitors.
AID1505494Antiviral activity against Influenza virus A/X-31 infected in HGPRT deficient 6-thioguanine-resistant MDCK cells assessed as reduction in viral replication at 3 days post infection by microscopic analysis2018Journal of medicinal chemistry, Jul-26, Volume: 61, Issue:14
Prodrugs of the Phosphoribosylated Forms of Hydroxypyrazinecarboxamide Pseudobase T-705 and Its De-Fluoro Analogue T-1105 as Potent Influenza Virus Inhibitors.
AID1505499Cytotoxicity against HGPRT deficient 6-thioguanine-resistant MDCK cells assessed as reduction in cell viability after 3 days by formazan-based MTS assay2018Journal of medicinal chemistry, Jul-26, Volume: 61, Issue:14
Prodrugs of the Phosphoribosylated Forms of Hydroxypyrazinecarboxamide Pseudobase T-705 and Its De-Fluoro Analogue T-1105 as Potent Influenza Virus Inhibitors.
AID1364949Antiviral activity against Chikungunya virus LR2006-OPY1 infected in African green monkey Vero-A cells assessed as inhibition of viral-induced cytopathic effect measured on day 7 post infection by MTS/PMS assay2017Bioorganic & medicinal chemistry, 08-15, Volume: 25, Issue:16
The medicinal chemistry of Chikungunya virus.
AID1364950Antiviral activity against Chikungunya virus venturini isolate (Italy 2008) infected in African green monkey Vero-A cells assessed as inhibition of viral-induced cytopathic effect measured on day 7 post infection by MTS/PMS assay2017Bioorganic & medicinal chemistry, 08-15, Volume: 25, Issue:16
The medicinal chemistry of Chikungunya virus.
AID1505497Antiviral activity against Influenza virus B/Ned/537/05 infected in HGPRT deficient 6-thioguanine-resistant MDCK cells assessed as reduction in viral replication at 3 days post infection by formazan-based MTS assay2018Journal of medicinal chemistry, Jul-26, Volume: 61, Issue:14
Prodrugs of the Phosphoribosylated Forms of Hydroxypyrazinecarboxamide Pseudobase T-705 and Its De-Fluoro Analogue T-1105 as Potent Influenza Virus Inhibitors.
AID1505524Antiviral activity against Influenza virus A/X-31 infected in MDCK cells assessed as inhibition of one cycle viral RNA sytheis at 250 uM added at 2 hrs post infection and measured at 10 hrs post infection by RT-qPCR method2018Journal of medicinal chemistry, Jul-26, Volume: 61, Issue:14
Prodrugs of the Phosphoribosylated Forms of Hydroxypyrazinecarboxamide Pseudobase T-705 and Its De-Fluoro Analogue T-1105 as Potent Influenza Virus Inhibitors.
AID1505551Antiviral activity against Influenza virus A/X-31 infected in MDCK cells assessed as inhibition of one cycle viral RNA sytheis at 12 to 50 uM added together with virus and measured at 10 hrs post infection by RT-qPCR method2018Journal of medicinal chemistry, Jul-26, Volume: 61, Issue:14
Prodrugs of the Phosphoribosylated Forms of Hydroxypyrazinecarboxamide Pseudobase T-705 and Its De-Fluoro Analogue T-1105 as Potent Influenza Virus Inhibitors.
AID1505536Antiviral activity against Influenza virus infected in human A549 cells2018Journal of medicinal chemistry, Jul-26, Volume: 61, Issue:14
Prodrugs of the Phosphoribosylated Forms of Hydroxypyrazinecarboxamide Pseudobase T-705 and Its De-Fluoro Analogue T-1105 as Potent Influenza Virus Inhibitors.
AID1505498Cytotoxicity against HGPRT deficient 6-thioguanine-resistant MDCK cells assessed as change in cell morphology after 3 days by microscopic analysis2018Journal of medicinal chemistry, Jul-26, Volume: 61, Issue:14
Prodrugs of the Phosphoribosylated Forms of Hydroxypyrazinecarboxamide Pseudobase T-705 and Its De-Fluoro Analogue T-1105 as Potent Influenza Virus Inhibitors.
AID1364948Antiviral activity against Chikungunya virus 899 infected in African green monkey Vero-A cells assessed as inhibition of viral-induced cytopathic effect measured on day 7 post infection by MTS/PMS assay2017Bioorganic & medicinal chemistry, 08-15, Volume: 25, Issue:16
The medicinal chemistry of Chikungunya virus.
AID1505492Cytotoxicity against MDCK cells assessed as change in cell morphology after 3 days by microscopic analysis2018Journal of medicinal chemistry, Jul-26, Volume: 61, Issue:14
Prodrugs of the Phosphoribosylated Forms of Hydroxypyrazinecarboxamide Pseudobase T-705 and Its De-Fluoro Analogue T-1105 as Potent Influenza Virus Inhibitors.
AID1505535Antiviral activity against Influenza virus A/X-31 infected in MDCK cells assessed as inhibition of one cycle viral RNA sytheis at 25 uM added together with virus and measured at 10 hrs post infection by RT-qPCR method2018Journal of medicinal chemistry, Jul-26, Volume: 61, Issue:14
Prodrugs of the Phosphoribosylated Forms of Hydroxypyrazinecarboxamide Pseudobase T-705 and Its De-Fluoro Analogue T-1105 as Potent Influenza Virus Inhibitors.
AID1505549Antiviral activity against Influenza virus A/X-31 infected in MDCK cells assessed as inhibition of one cycle viral RNA sytheis at 250 uM added together with virus and measured at 10 hrs post infection by RT-qPCR method2018Journal of medicinal chemistry, Jul-26, Volume: 61, Issue:14
Prodrugs of the Phosphoribosylated Forms of Hydroxypyrazinecarboxamide Pseudobase T-705 and Its De-Fluoro Analogue T-1105 as Potent Influenza Virus Inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (9.09)29.6817
2010's6 (54.55)24.3611
2020's4 (36.36)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.37 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index5.49 (4.65)
Search Engine Demand Index17.79 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (18.18%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (81.82%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]